
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $14.2M | $26.8M | $36.5M | |
Revenue Growth (YoY) | -- | -- | -- | 88.36% | 36.07% | |
Cost of Revenues | -- | -- | $1.7M | $2.9M | $4.2M | |
Gross Profit | -- | -- | $12.5M | $23.9M | $32.3M | |
Gross Profit Margin | -- | -- | 88.03% | 89.26% | 88.59% | |
R&D Expenses | $220.8M | $257M | $279.9M | $295.5M | $301.3M | |
Selling, General & Admin | $115.1M | $121.4M | $121.7M | $119.9M | $156.8M | |
Other Inc / (Exp) | -- | $21.1M | $144.5M | $6.1M | $1.1B | |
Operating Expenses | $335.9M | $378.4M | $401.6M | $415.4M | $458.1M | |
Operating Income | -$335.9M | -$378.4M | -$389M | -$391.5M | -$425.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$329.3M | -$356.5M | -$231.8M | -$352.1M | $718M | |
Earnings of Discontinued Ops. | $1.9M | $2B | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | $44.2M | |
Net Income to Company | -$329.3M | -$356.5M | -$231.8M | -$352.1M | $673.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$327.4M | $1.6B | -$231.8M | -$352.1M | $673.7M | |
Basic EPS (Cont. Ops) | -$4.74 | $26.55 | -$4.23 | -$6.33 | $11.86 | |
Diluted EPS (Cont. Ops) | -$4.74 | $26.55 | -$4.23 | -$6.33 | $11.64 | |
Weighted Average Basic Share | $69M | $60.4M | $54.8M | $55.7M | $56.8M | |
Weighted Average Diluted Share | $69M | $60.4M | $54.8M | $55.7M | $57.9M | |
EBITDA | -$326.1M | -$369.2M | -$380.5M | -$384.9M | -$420.1M | |
EBIT | -$335.9M | -$378.4M | -$389M | -$391.5M | -$425.7M | |
Revenue (Reported) | -- | -- | $14.2M | $26.8M | $36.5M | |
Operating Income (Reported) | -$335.9M | -$378.4M | -$389M | -$391.5M | -$425.7M | |
Operating Income (Adjusted) | -$335.9M | -$378.4M | -$389M | -$391.5M | -$425.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $832K | $5.6M | $8.2M | $8.7M | |
Revenue Growth (YoY) | -- | -- | 574.16% | 46% | 6.56% | |
Cost of Revenues | -- | $339K | $554K | $627K | $1.1M | |
Gross Profit | -- | $493K | $5.1M | $7.6M | $7.6M | |
Gross Profit Margin | -- | 59.26% | 90.12% | 92.34% | 87.57% | |
R&D Expenses | $57.7M | $70.1M | $67.3M | $68.6M | $72.7M | |
Selling, General & Admin | $33.6M | $31.5M | $28.4M | $31M | $41.5M | |
Other Inc / (Exp) | -- | $5.7M | $1.5M | $1.6M | $1.3M | |
Operating Expenses | $91.2M | $101.6M | $95.7M | $99.6M | $114.3M | |
Operating Income | -$91.2M | -$101.1M | -$90.6M | -$92.1M | -$106.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$90.9M | -$94.8M | -$81M | -$81.5M | -$89.3M | |
Earnings of Discontinued Ops. | $2B | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$90.9M | -$94.8M | -$81M | -$81.5M | -$89.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $1.9B | -$94.8M | -$81M | -$81.5M | -$89.3M | |
Basic EPS (Cont. Ops) | $26.95 | -$1.74 | -$1.47 | -$1.45 | -$1.55 | |
Diluted EPS (Cont. Ops) | $26.95 | -$1.74 | -$1.47 | -$1.45 | -$1.55 | |
Weighted Average Basic Share | $69.5M | $54.6M | $55.3M | $56.4M | $57.5M | |
Weighted Average Diluted Share | $69.5M | $54.6M | $55.3M | $56.4M | $57.5M | |
EBITDA | -$88.7M | -$98.7M | -$88.8M | -$90.7M | -$105.4M | |
EBIT | -$91.2M | -$101.1M | -$90.6M | -$92.1M | -$106.6M | |
Revenue (Reported) | -- | $832K | $5.6M | $8.2M | $8.7M | |
Operating Income (Reported) | -$91.2M | -$101.1M | -$90.6M | -$92.1M | -$106.6M | |
Operating Income (Adjusted) | -$91.2M | -$101.1M | -$90.6M | -$92.1M | -$106.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $19M | $29.4M | $37M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | $1.9M | $3M | $4.6M | |
Gross Profit | -- | $493K | $17.1M | $26.4M | $32.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $223.1M | $269.4M | $277.1M | $296.8M | $305.4M | |
Selling, General & Admin | $117M | $119.4M | $118.5M | $122.6M | $167.3M | |
Other Inc / (Exp) | -- | $26.7M | $140.3M | $6.2M | $1.1B | |
Operating Expenses | $340.1M | $388.8M | $395.6M | $419.4M | $472.7M | |
Operating Income | -$340.1M | -$388.3M | -$378.5M | -$392.9M | -$440.3M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$336.1M | -$360.4M | -$218M | -$352.6M | $710.2M | |
Earnings of Discontinued Ops. | $1.9B | -$4M | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$336.1M | -$360.4M | -$218M | -$352.6M | $666M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $1.6B | -$364.4M | -$218M | -$352.6M | $666M | |
Basic EPS (Cont. Ops) | $22.80 | -$6.45 | -$3.97 | -$6.32 | $11.69 | |
Diluted EPS (Cont. Ops) | $22.80 | -$6.45 | -$3.97 | -$6.32 | $11.24 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$330.3M | -$379.1M | -$370.6M | -$386.8M | -$434.7M | |
EBIT | -$340.1M | -$388.3M | -$378.5M | -$392.9M | -$440.3M | |
Revenue (Reported) | -- | -- | $19M | $29.4M | $37M | |
Operating Income (Reported) | -$340.1M | -$388.3M | -$378.5M | -$392.9M | -$440.3M | |
Operating Income (Adjusted) | -$340.1M | -$388.3M | -$378.5M | -$392.9M | -$440.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $832K | $5.6M | $8.2M | $8.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $339K | $554K | $627K | $1.1M | |
Gross Profit | -- | $493K | $5.1M | $7.6M | $7.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $57.7M | $70.1M | $67.3M | $68.6M | $72.7M | |
Selling, General & Admin | $33.6M | $31.5M | $28.4M | $31M | $41.5M | |
Other Inc / (Exp) | -- | $5.7M | $1.5M | $1.6M | $1.3M | |
Operating Expenses | $91.2M | $101.6M | $95.7M | $99.6M | $114.3M | |
Operating Income | -$91.2M | -$101.1M | -$90.6M | -$92.1M | -$106.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$90.9M | -$94.8M | -$81M | -$81.5M | -$89.3M | |
Earnings of Discontinued Ops. | $2B | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$90.9M | -$94.8M | -$81M | -$81.5M | -$89.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $1.9B | -$94.8M | -$81M | -$81.5M | -$89.3M | |
Basic EPS (Cont. Ops) | $26.95 | -$1.74 | -$1.47 | -$1.45 | -$1.55 | |
Diluted EPS (Cont. Ops) | $26.95 | -$1.74 | -$1.47 | -$1.45 | -$1.55 | |
Weighted Average Basic Share | $69.5M | $54.6M | $55.3M | $56.4M | $57.5M | |
Weighted Average Diluted Share | $69.5M | $54.6M | $55.3M | $56.4M | $57.5M | |
EBITDA | -$88.7M | -$98.7M | -$88.8M | -$90.7M | -$105.4M | |
EBIT | -$91.2M | -$101.1M | -$90.6M | -$92.1M | -$106.6M | |
Revenue (Reported) | -- | $832K | $5.6M | $8.2M | $8.7M | |
Operating Income (Reported) | -$91.2M | -$101.1M | -$90.6M | -$92.1M | -$106.6M | |
Operating Income (Adjusted) | -$91.2M | -$101.1M | -$90.6M | -$92.1M | -$106.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $127.4M | $203.1M | $139.3M | $88.2M | $76.2M | |
Short Term Investments | $445.5M | $816.9M | $643.9M | $688.7M | $817.5M | |
Accounts Receivable, Net | -- | -- | $2.2M | $2.8M | $4.1M | |
Inventory | -- | -- | $8.5M | $19.1M | $27.6M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $15.9M | $39.8M | $39M | $35M | $40.2M | |
Total Current Assets | $636.7M | $1.1B | $832.8M | $833.8M | $965.6M | |
Property Plant And Equipment | $116.1M | $104.2M | $88.1M | $69.8M | $54.6M | |
Long-Term Investments | $97.6M | $266.4M | $313.9M | $29.4M | $638.3M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $2.6M | $2.9M | $4M | $4.1M | $4.7M | |
Total Assets | $853M | $1.4B | $1.2B | $937.1M | $1.7B | |
Accounts Payable | $17.7M | $16.7M | $18.6M | $9.8M | $16.6M | |
Accrued Expenses | $10.5M | $12.1M | $12.2M | $19.9M | $16.9M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $7.4M | $11.2M | $13.7M | $15M | $16.8M | |
Other Current Liabilities | $38.5M | -- | -- | -- | -- | |
Total Current Liabilities | $94.4M | $59.8M | $62.6M | $68M | $81.2M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $453.5M | $145.8M | $137.9M | $126.1M | $122.2M | |
Common Stock | $69K | $71K | $71K | $72K | $73K | |
Other Common Equity Adj | $105K | -$1.2M | -$12.5M | -$441K | -$1.5M | |
Common Equity | $399.5M | $1.3B | $1.1B | $811M | $1.5B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $399.5M | $1.3B | $1.1B | $811M | $1.5B | |
Total Liabilities and Equity | $853M | $1.4B | $1.2B | $937.1M | $1.7B | |
Cash and Short Terms | $572.9M | $1B | $783.1M | $776.9M | $893.7M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.9B | $80M | $104.1M | $118.8M | $79M | |
Short Term Investments | $447.6M | $843.5M | $635.1M | $479.2M | $814.4M | |
Accounts Receivable, Net | -- | $540K | $1.8M | $3.5M | $3.3M | |
Inventory | -- | $2.5M | $11.4M | $23.1M | $29.6M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $19.5M | $43.2M | $39.3M | $39.1M | $42.3M | |
Total Current Assets | $2.4B | $975.1M | $791.7M | $663.6M | $968.6M | |
Property Plant And Equipment | $111.7M | $102M | $84M | $65.7M | $50.9M | |
Long-Term Investments | $21.6M | $255.8M | $271.7M | $116.3M | $531.3M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | $2.9M | $4M | $4.1M | $4.7M | |
Total Assets | $2.5B | $1.3B | $1.2B | $849.7M | $1.6B | |
Accounts Payable | $51.2M | $11.6M | $8.7M | $11.2M | $13.7M | |
Accrued Expenses | $16.3M | $14.4M | $15.8M | $19.7M | $13M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $8.3M | $12M | $14M | $15.4M | $17.2M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $96.5M | $45.8M | $45.1M | $51.7M | $52.4M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $191.8M | $128.4M | $114.8M | $105.8M | $89M | |
Common Stock | $70K | $71K | $72K | $73K | $74K | |
Other Common Equity Adj | -$3K | -$7.7M | -$8.4M | -$1.1M | $365K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $2.3B | $1.2B | $1B | $743.9M | $1.5B | |
Total Liabilities and Equity | $2.5B | $1.3B | $1.2B | $849.7M | $1.6B | |
Cash and Short Terms | $2.3B | $923.5M | $739.2M | $598M | $893.4M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$329.3M | -$356.5M | -$231.8M | -$352.1M | $673.7M | |
Depreciation & Amoritzation | $9.8M | $9.2M | $8.6M | $6.6M | $5.7M | |
Stock-Based Compensation | $61.6M | $53.5M | $49.3M | $44.8M | $42.8M | |
Change in Accounts Receivable | -- | -$4.4M | -$1.8M | -$604K | -$1.3M | |
Change in Inventories | -- | -- | -$8.5M | -$10.6M | -$8.5M | |
Cash From Operations | -$290.8M | -$407.3M | -$309.5M | -$296.1M | -$389.8M | |
Capital Expenditures | $14.1M | $5.7M | $4.9M | $18.5M | $1.7M | |
Cash Acquisitions | -- | -- | $131.8M | -- | $1.1B | |
Cash From Investing | $75.7M | $1.2B | $243.3M | $239.6M | $363.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$336K | -$578K | -$331K | -- | -- | |
Repurchase of Common Stock | -- | -$802.5M | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $261.5M | -$765.8M | $2.4M | $5.4M | $14.4M | |
Beginning Cash (CF) | $80.9M | $127.4M | $203.1M | $139.3M | $88.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $46.5M | $75.7M | -$63.9M | -$51.1M | -$12M | |
Ending Cash (CF) | $127.4M | $203.1M | $139.3M | $88.2M | $76.2M | |
Levered Free Cash Flow | -$304.9M | -$413.1M | -$314.4M | -$314.6M | -$391.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$90.9M | -$94.8M | -$81M | -$81.5M | -$89.3M | |
Depreciation & Amoritzation | $2.5M | $2.5M | $1.8M | $1.3M | $1.3M | |
Stock-Based Compensation | $14.9M | $15.5M | $10.1M | $9.2M | $11.4M | |
Change in Accounts Receivable | -- | -$1.5M | $428K | -$643K | $765K | |
Change in Inventories | -- | -$2.5M | -$2.9M | -$4M | -$2M | |
Cash From Operations | -$120.7M | -$97.7M | -$95.2M | -$99.9M | -$111.5M | |
Capital Expenditures | $1M | $2.8M | $399K | $141K | $766K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $1.9B | -$26.6M | $57.6M | $124.6M | $112.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$86K | -$81K | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $7.3M | $1.2M | $2.5M | $5.9M | $1.6M | |
Beginning Cash (CF) | $127.4M | $203.1M | $139.3M | $88.2M | $76.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.8B | -$123.1M | -$35.1M | $30.6M | $2.7M | |
Ending Cash (CF) | $1.9B | $80M | $104.1M | $118.8M | $79M | |
Levered Free Cash Flow | -$121.8M | -$100.5M | -$95.6M | -$100M | -$112.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$336.1M | -$360.4M | -$218M | -$352.6M | $666M | |
Depreciation & Amoritzation | $9.8M | $9.2M | $7.9M | $6.2M | $5.6M | |
Stock-Based Compensation | $60.8M | $54.2M | $43.9M | $43.9M | $45M | |
Change in Accounts Receivable | -- | -$5.9M | $196K | -$1.7M | $109K | |
Change in Inventories | -- | -$2.5M | -$8.9M | -$11.7M | -$6.5M | |
Cash From Operations | -$306.2M | -$384.3M | -$306.9M | -$300.7M | -$401.5M | |
Capital Expenditures | $10.9M | $7.5M | $2.5M | $18.2M | $2.3M | |
Cash Acquisitions | -- | -- | -- | -- | $1.1B | |
Cash From Investing | $1.8B | -$651.9M | $327.4M | $306.5M | $351.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$342K | -$573K | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $263.4M | -$771.8M | $3.6M | $8.8M | $10.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.8B | -$1.8B | $24.1M | $14.6M | -$39.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$317.1M | -$391.8M | -$309.4M | -$319M | -$403.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$90.9M | -$94.8M | -$81M | -$81.5M | -$89.3M | |
Depreciation & Amoritzation | $2.5M | $2.5M | $1.8M | $1.3M | $1.3M | |
Stock-Based Compensation | $14.9M | $15.5M | $10.1M | $9.2M | $11.4M | |
Change in Accounts Receivable | -- | -$1.5M | $428K | -$643K | $765K | |
Change in Inventories | -- | -$2.5M | -$2.9M | -$4M | -$2M | |
Cash From Operations | -$120.7M | -$97.7M | -$95.2M | -$99.9M | -$111.5M | |
Capital Expenditures | $1M | $2.8M | $399K | $141K | $766K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $1.9B | -$26.6M | $57.6M | $124.6M | $112.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$86K | -$81K | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $7.3M | $1.2M | $2.5M | $5.9M | $1.6M | |
Beginning Cash (CF) | $127.4M | $203.1M | $139.3M | $88.2M | $76.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.8B | -$123.1M | -$35.1M | $30.6M | $2.7M | |
Ending Cash (CF) | $1.9B | $80M | $104.1M | $118.8M | $79M | |
Levered Free Cash Flow | -$121.8M | -$100.5M | -$95.6M | -$100M | -$112.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.